cbdMD (YCBD) FFO


YCBD cbdMD Inc YCBD
38 GF Score
Price $0.71
GF Value $0.16
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is cbdMD FFO?

FFO (Funds from operations) only applies to REITs.

YCBD
38GF Score
cbdMD Inc YCBD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is cbdMD (YCBD) Overvalued in 2026?

Based on GuruFocus' analysis, cbdMD stock appears to be overvalued. The current stock price of $0.71 is trading 346% above its estimated GF Value™ of $0.16. GuruFocus considers cbdMD to be Significantly Overvalued.

Key valuation signals for YCBD:

  • FFO:
  • GF Value™: $0.16 vs. price of $0.71 (346% above fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

cbdMD Business Description

Address 2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
38GF Score

Get the complete analysis for YCBD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price
$0.16
GF Value